Clinical trial
No Resistance After Long Term Treatment SERETIDE
NCT00456313 · GlaxoSmithKline, Industry · Withdrawn
Key facts
| NCT number | NCT00456313 |
|---|---|
| Title | No Resistance After Long Term Treatment SERETIDE |
| Official title | Rationale for Therapy With Low Dose Steroids Combined With Long-acting beta2-agonists in Patients With Allergic Asthma: Redirecting Innate Immune Responses by Long-term Treatment With High Doses of Inhaled Steroids |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | FLIXOTIDE and SERETIDE |
| Enrollment | 0 |
| Start date | Dec 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 4, 2007 |
| Last update posted | Apr 17, 2015 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: